Bradford Crutchfield, Chief Commercial Officer at 10x Genomics, Inc. (TXG), sold 30,200 shares at $176.94 ($5.3M) on 2021-02-01, disclosed to the SEC on 2021-02-03.
Open-market sale of $5.3M TXG by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $173.99 | 746 | $130K | 2.4% |
| 2 | $173.99 | 746 | $130K | 2.4% |
| 3 | $175.25 | 4,003 | $702K | 13.2% |
| 4 | $175.25 | 4,003 | $702K | 13.2% |
| 5 | $175.94 | 8,451 | $1.5M | 28.0% |
| 6 | $175.94 | 8,451 |
| $1.5M |
| 28.0% |
| 7 | $176.94 | 2,700 | $478K | 9.0% |
| 8 | $177.86 | 900 | $160K | 3.0% |
| 9 | $178.92 | 200 | $36K | 0.7% |
| Total | $175.83 avg | 30,200 | $5.3M | 100% |
| Filing → |
| TXG | SELL | 2022-02-24 | $23K | — | Filing → |
| TXG | SELL | 2022-02-17 | $1.6M | — | Filing → |
| TXG | SELL | 2022-01-14 | $3.5M | — | Filing → |